Hypersensitivity reactions such as pruritus, rash, urticaria, anaphylactic or anaphylactoid reactions with angioneurotic edema or bronchospasm may occur in isolated cases and usually disappear rapidly after discontinuation of the drug treatment.
A few very rare events of' bleeding (e.g. skin, mucosa) have been reported in patients treated with Pentoxifylline with and without anticoagulants or platelet aggregation inhibitors. The serious cases are predominantly concentrated in the gastrointestinal, genitourinary, multiple site and surgical wound areas and are associated with bleeding risk factors. A causal relationship between Pentoxifylline therapy and bleeding has not been established.
Thrombocytopenia has occurred in isolated cases.
View ADR Reporting Link